Liver fibrosis together with PNPLA3 p.I148M variant affects quality of life in patients with non-alcoholic fatty liver disease: prospective liver stiffness-based study

被引:0
|
作者
Heintz, Lena [1 ]
Holz, Robert [1 ]
Weber, Susanne N. [1 ]
Lammert, Frank [1 ]
Krawczyk, Marcin [1 ,2 ]
机构
[1] Saarland Univ Hosp, Dept Internal Med 2, Homburg, Germany
[2] Med Univ Warsaw, Lab Metab Liver Dis, Dept Gen Transplant & Liver Surg, Warsaw, Poland
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT-303
引用
收藏
页码:E772 / E772
页数:1
相关论文
共 50 条
  • [1] PNPLA3 I148M variant affects non-alcoholic fatty liver disease in liver transplant recipients
    Liu, Zheng-Tao
    Chen, Tian-Chi
    Lu, Xiao-Xiao
    Cheng, Jun
    Xie, Hai-Yang
    Zhou, Lin
    Zheng, Shu-Sen
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (34) : 10054 - 10056
  • [2] PNPLA3 I148M variant affects non-alcoholic fatty liver disease in liver transplant recipients
    Zheng-Tao Liu
    Tian-Chi Chen
    Xiao-Xiao Lu
    Jun Cheng
    Hai-Yang Xie
    Lin Zhou
    Shu-Sen Zheng
    World Journal of Gastroenterology, 2015, (34) : 10054 - 10056
  • [3] PNPLA3 VARIANT p.I148M IMPROVES RESPONSE TO BARIATRIC SURGERY IN OBESE PATIENTS WITH FATTY LIVER DISEASE
    Krawczyk, M.
    Jimenez-Agueero, R.
    Aluztiza, J. M.
    Emparanza, J. I.
    Lammert, F.
    Banales, J. M.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S753 - S754
  • [4] The I148M Variant of PNPLA3 Reduces the Response to Docosahexaenoic Acid in Children with Non-Alcoholic Fatty Liver Disease
    Nobili, Valerio
    Bedogni, Giorgio
    Donati, Benedetta
    Alisi, Anna
    Valenti, Luca
    JOURNAL OF MEDICINAL FOOD, 2013, 16 (10) : 957 - 960
  • [5] Reduction of caloric intake overrides the prosteatotic effects of the PNPLA3 p.I148M variant in patients with fatty liver: ultrasound-based prospective study
    Krawczyk, M.
    Stachowska, E.
    Milkiewicz, P.
    Lammert, F.
    Milkiewicz, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2015, 45 : 14 - 14
  • [6] Effect of PNPLA3 I148M polymorphism on histologically proven non-alcoholic fatty liver disease in liver transplant recipients
    Kim, Hyeyoung
    Lee, Kwang-Woong
    Lee, Kyoungbun
    Seo, Sooin
    Park, Min-Young
    Ahn, Sung Woo
    Hong, Suk Kyun
    Yoon, Kyung Chul
    Kim, Hyo-Sin
    Choi, YoungRok
    Lee, Hae Won
    Yi, Nam-Joon
    Suh, Kyung-Suk
    HEPATOLOGY RESEARCH, 2018, 48 (03) : E162 - E171
  • [7] Patient-derived liver organoids to reveal PNPLA3 I148M role in Non-Alcoholic Fatty Liver Disease
    Casirati, Elia
    Cherubini, Alessandro
    Tomasi, Melissa
    Marini, Ilaria
    Prati, Daniele
    Dondossola, Daniele
    Valenti, Luca
    JOURNAL OF HEPATOLOGY, 2022, 77 : S668 - S668
  • [8] I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders
    Xia, M. -F.
    Ling, Y.
    Bian, H.
    Lin, H. -D.
    Yan, H. -M.
    Chang, X. -X.
    Li, X. -M.
    Ma, H.
    Wang, D.
    Zhang, L. -S.
    Wang, S. -S.
    Wu, B. -J.
    He, W. -Y.
    Zhao, N. -Q.
    Gao, X.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (05) : 631 - 642
  • [9] I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders
    Xia, Mingfeng
    Ling, Yan
    Lin, Huandong
    Yan, Hongmei
    Chang, Xinxia
    Zhang, Linshan
    Gao, Xin
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2016, 32 (SUPP 2) : 9 - 10
  • [10] Hepatic copper and PNPLA3 in patients with non-alcoholic fatty liver disease
    Staettermayer, Albert
    Traussnigg, Stefan
    Aigner, Elmar
    Kienbacher, Christian
    Steindl-Munda, Petra E.
    Datz, Christian
    Wrba, Fritz
    Trauner, Michael
    Ferenci, Peter
    HEPATOLOGY, 2014, 60 : 609A - 609A